In type 2 diabetes, GLP-1 RA plus SGLT2 inhibitor vs. either drug alone reduces HbA1c and SBP and may reduce body weight. Tanner M. Ann Intern Med 2020;173:JC52.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tanner M. In type 2 diabetes, GLP-1 RA plus SGLT2 inhibitor vs. either drug alone reduces HbA1c and SBP and may reduce body weight. Ann Intern Med 2020;173:JC52.
PMID: 33197349